1. Home
  2. IPAR
  3. Earnings

AI Earnings Predictions for Inter Parfums Inc. (IPAR)

Machine learning predictions based on historical earnings data and price patterns

Latest Prediction

BUY

1-Day Prediction

+4.89%

$108.00

100% positive prob.

5-Day Prediction

+5.69%

$108.83

100% positive prob.

20-Day Prediction

+10.01%

$113.28

95% positive prob.

Price at prediction: $102.97 Confidence: 100.0% Model AUC: 1.0000 Quarter: Q4 2025

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K BUY

Feb 24, 2026 · 100% conf.

AI Prediction BUY

1D

+4.89%

$108.00

Act: -1.32%

5D

+5.69%

$108.83

Act: -7.25%

20D

+10.01%

$113.28

Price: $102.97 Prob +5D: 100% AUC: 1.000
0001753926-26-000347

ipar-20260224.htm

false 0000822663 NY 00008226632026-02-242026-02-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 24, 2026

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated February 24, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 3rd through 6th full paragraphs relating to operational results for the four quarter of 2025 or full year ended December 31, 2025

Portion of 7th paragraph relating to operational results for the four quarter of 2025 or full year ended December 31, 2025

The 10th, 12th through 16th full paragraphs relating to results of operations

Part of the 11th paragraph relating to results of operations

The 17th paragraph relating to balance sheet information

The tables of unaudited consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated February 24, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

The last sentence in the 7th paragraph relating to Lacoste and Cavalli future launches

The 8th full paragraph relating future product launches for several brands, and the 15 year extension of the Guess license to help navigate the fragrance markets short-term volatility and deliver long-term results for the Company

The 9th full paragraph relating to future investments we are making towards product innovation that may allow the Company to see cautious optimism for 2026 and more favorable operating environment for 2027

Portion of the 11th paragraph relating to the future impact of tariffs on our business and the strategies and programs we are going to implement in 2026 to offset the possible effects

Paragraphs 18 through 19 relating to 2026 guidance

The 22nd through 25th paragraphs relating to the conference call to discuss the 2025 fourth quarter and 2025 full year results scheduled for February 25, 2026

The 28th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02 or 8.01

Item 8.01 Financial Statements and Exhibits.

The 20th and 21st paragraphs relating to our cash dividend are incorporated by reference herein

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated February 24, 2026

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: February 24, 2026

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q4

Q4 2025 Earnings

8-K BUY

Jan 21, 2026 · 100% conf.

AI Prediction BUY

1D

+4.89%

$108.00

Act: -1.32%

5D

+5.69%

$108.83

Act: -7.25%

20D

+10.01%

$113.28

Price: $102.97 Prob +5D: 100% AUC: 1.000
0001753926-26-000158

ipar-20260121.htm

false 0000822663 NY 00008226632026-01-212026-01-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 21, 2026

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated January 21, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

· The 1st, 2nd (consisting of a table), 3rd through 8th full paragraphs relating to net sales for the fourth quarter of 2025 or the full year ended December 31, 2025

· The 11th through 16th full paragraphs relating to net sales for the quarter of 2025 or the full year ended December 31, 2025

· The 17th through 19th paragraphs relating to the date for the issuance of financial results and earnings conference call details.

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated January 21, 2026, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

· The 9th full paragraph relating to the launch of our proprietary brand, Solférino

· The 10th full paragraph relating to the 2 year extension of the Boucheron license for existing fragrance lines

· The 22nd paragraph relating to forward-looking information

· The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated January 21, 2026

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated:

January 21, 2026

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q3

Q3 2025 Earnings

8-K

Nov 5, 2025

0001753926-25-001705

ipar-20251105.htm

false NY 0000822663 00008226632025-11-052025-11-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 5, 2025

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated November 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 7th and 9th through 12th full paragraphs relating to the results of operations for the first nine (9) months and third quarter of 2025

Portion of the 3rd paragraph relating to factors that affected the Company’s topline growth

Portion of the 8th paragraph relating to results of operations for the third quarter and nine (9) months ended September 30, 2025

The 4th and 5th paragraphs relating to sales by territory for the 2025 third quarter

The 13th paragraph relating to balance sheet, operating cash flow and working capital efficiency

The 18th through 22nd paragraphs relating to the previously announced conference call for the 2025 third quarter results

The unaudited consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated November 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

The 3rd paragraph relating to the Company’s planned innovation pipelines, rigorous advertising and promotion programs and portfolio evolution to impact potential sales for the fourth quarter of 2025 and into 2026

The 6th paragraph relating to the Company’s 2025 holiday sales through differentiated product offerings, targeting marketing initiatives and increased brand visibility

The 14th paragraph relating to updating the projected guidance for the remainder of the 2025 year

The 15th paragraph relating to the initial 2026 guidance issuance date

The 25th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in 2.02

Item 8.01 Other Events

The 16th paragraph relating to dividends

The 17th paragraph relating to the Company’s plan to streamline its corporate structure whereby the wholly owned French subsidiary, Inter Parfums Holdings SA, will merge into Interparfums SA, the Company’s French operating subsidiary, with Interparfums SA becoming the surviving entity in December 2025

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated November 5, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: November 5, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q3

Q3 2025 Earnings

8-K

Oct 20, 2025

0001753926-25-001633

ipar-20251020.htm

false 0000822663 NY 00008226632025-10-202025-10-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 20, 2025

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated October 20, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), and 3rd, 5th, 7th, and 10th full paragraphs relating to net sales for the third quarter and nine (9) months ended September 30, 2025

Portions of the 4th, 6th 8th and 9th paragraphs relating to net sales for the third quarter and nine (9) months ended September 30, 2025

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated October 20, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

Portion of the 4th paragraph relating to potential future Lacoste sales levels

Portion of the 6th paragraph relating to the new

Montblanc fragrance and its potential for the remainder of 2025 and 2026

Portion of the 8th paragraph relating to GUESS’ potential sales in the fourth quarter of 2025

Portion of the 9th paragraph relating to Donna Karan/DKNY potential holiday sales in the fourth quarter of 2025

Portion of the 11th paragraph relating to the Company’s future pricing increase, planned innovation pipelines, macroeconomic headwinds and potential sales for the 2025 fourth quarter and 2026

The 12th paragraph relating to the Company’s plans to release its earnings for the three and nine months ended September 30, 2025 on Wednesday, November 5, 2025

Portion of the 12th paragraph and the 13th through 15th full paragraphs relating to the conference call scheduled for November 6, 2025

The 18th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in 2.02

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated October 20, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: October 20, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q2

Q2 2025 Earnings

8-K

Aug 5, 2025

0001753926-25-001238

ipar-20250805.htm

NY false 0000822663 00008226632025-08-052025-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 5, 2025

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated August 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 4th , 5th , 8th through 12th full paragraphs relating to results of operations for the second quarter of 2025

Part of the 3rd paragraph relating to results of operations for the second quarter of 2025

The 13th paragraph relating to balance sheet items, cash flow, inventory and supply chain

The 17th through 22nd paragraphs relating to the previously announced conference call scheduled for August 6, 2025

The consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated August 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

Portion of the 3rd paragraph relating to anticipating headwinds for the remainder of the year, along with an action plan to hopefully overcome said headwinds

The 6th paragraph relating to the previously announced license agreements for Longchamp, Off- White and Goutal, as well as the Solferino flagship store opening next month in Paris

The 7th paragraph relating to the potential impact of tariffs, recent pricing strategies, upcoming fragrance launches and foreign exchange tailwinds on the Company as it enters the second half of 2025

The 14th and 15th paragraphs relating to reaffirmance of the previously announced 2025 guidance for the Company

The 23rd paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 8.01 Other Events

The 16th paragraph relating to Dividends

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated August 5, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: August 5, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q2

Q2 2025 Earnings

8-K

Jul 23, 2025

0001753926-25-001171

ipar-20250723.htm

NY false 0000822663 00008226632025-07-232025-07-23

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 23, 2025

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated July 23, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), and 3rd full paragraphs relating to net sales for the second quarter and six (6) months ended June 30, 2025

Parts of the 4th through 9th paragraph relating to net sales for the second quarter ended June 30, 2025

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated July 23, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

Portion of the 4th paragraph relating to the Company’s confidence in the market for the remainder of the year

Portion of the 5th paragraph relating to potential future Lacoste sales levels

Portion of the 6th paragraph relating to Montblanc's future sales for the remainder of the year

Portion of the 7th paragraph relating to the minimal impact on the Company’s future quarter-over-quarter comparisons stemming from the discontinuation of the Dunhill license

Portion of the 8th paragraph relating to Guess and Donna Karan/DKNY marketing plans and innovation for the remainder of the year

Portion of the 9th paragraph relating to the Company’s future pricing increase, planned innovation pipelines, foreign exchange headwinds and potential sales for the second half of 2025

The 10th paragraph relating to the Company’s plans to release its earnings for the three and six months ended June 30, 2025 on Tuesday, August 5, 2025

Portion of the 10th paragraph and the 11th through 13th full paragraphs relating to the conference call scheduled for August 6, 2025

The 16th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in 2.02

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated July 23, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: July 23, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q1

Q1 2025 Earnings

8-K

May 5, 2025

0001753926-25-000740

ipar-20250505.htm

0000822663 false NY

0000822663

2025-05-05 2025-05-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 5, 2025

Interparfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated May 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 3rd through 5th, 8th, and 9th through 16th full paragraphs relating to results of operations for the first quarter of 2025

The 17th paragraph relating to balance sheet items and cash flow

The 18th paragraph relating to inventory and supply chain

The 22nd through 24th paragraphs relating to the previously announced conference call scheduled for May 6, 2025

The consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated May 5, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

Portion of the 6th paragraph relating to the Company’s portfolio of future innovation pipelines, including new blockbusters and product extension lines for the remainder of the year and the previously announced Coach license extension

The 7th paragraph relating to future 2026 plans for the recently acquired Annick Goutal brand and the 2026 launch of the Company’s first proprietary brand, Solférino

The 19th paragraph relating to the potential impact of tariffs on the Company’s supply chain, as well as the possibility of a price increase on select brands in August 2025

The 20th paragraph relating to reaffirmance of the previously announced 2025 guidance for the Company

The 27th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 8.01 Other Events

The 21st paragraph relating to Dividends

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated May 5, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: May 5, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2025
Q1

Q1 2025 Earnings

8-K

Apr 23, 2025

0001753926-25-000674

ipar-20250423.htm

NY false 0000822663

0000822663

2025-04-23 2025-04-23

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 23, 2025

Interparfums, Inc. (Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated April 23, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

• The 1st, 2nd (consisting of a table), 3rd, 5th and 6th full paragraphs relating to net sales for the first quarter ended March 31, 2025

• Part of the 4th paragraph relating to net sales for the first quarter ended March 31, 2025

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated April 23, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

• Portion of the 4th paragraph relating to potential future Montblanc sales and a new product launch planned for later in the year

The 7th paragraph relates to 2025 business challenges relating to tariffs and August 2025 price increases on certain lines

• The 8th paragraph relating to reaffirmance of the previously announced 2025 guidance for the Company

Portion of the 9th paragraph relating to plans to release 2025 first quarter results on May 5, 2025, and the conference call scheduled for May 6, 2025

The 10th through 14th full paragraphs relating to the conference call scheduled for May 6, 2025

• The 15th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated April 23, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated:  April 23, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2024
Q4

Q4 2024 Earnings

8-K

Feb 25, 2025

0001753926-25-000284

ipar-20250225.htm

0000822663 false NY

0000822663

2025-02-25 2025-02-25

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): February 25, 2025

Interparfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated February 25, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 3rd through 6th full paragraphs relating to operational results for the fourth quarter of 2024 or the full year ended December 31, 2024

Portions of the 7th, 8th, and 10th paragraphs relating to operational results for the fourth quarter of 2024 or the full year ended December 31, 2024

The 11th -14th paragraphs relating to results of operations

The 15th paragraph relating to balance sheet information

The 20th through 23rd paragraphs relating to the already communicated conference call scheduled for February 26, 2025

The tables of unaudited consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated February 25, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

Portion of the 7th paragraph relating to strong programs and momentum of GUESS in 2025

Portion of the 8th paragraph relating to Lacoste and Roberto Cavalli's future growth with the Company in the coming years

The 9th paragraph relating to the Company’s plans for new product launches and brand extensions for both the European and United States based operations, as well as the 2025 launch of the Company’s first proprietary niche brand, Solférino

Portion of the 10th paragraph relating to the solid level of reorders for the first half of 2025

Paragraphs 16 through 17 relating to 2025 guidance

The 26th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02 or 8.01

Item 8.01 Other Matters

The 18th and 19th paragraphs relating to the increase of our cash dividend are incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated February 25, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: February 25, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

2024
Q4

Q4 2024 Earnings

8-K

Jan 22, 2025

0001753926-25-000118

ipar-20250122.htm

NY false 0000822663

0000822663

2025-01-22 2025-01-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 22, 2025

Interparfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Conditions

Certain portions of our press release dated January 22, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 3rd, and 5th through 12th full paragraphs relating to net sales for the fourth quarter of 2024 or the full year ended December 31, 2024.

The portion of the 4th paragraph relating to net sales for the fourth quarter of 2024 or the full year ended December 31, 2024.

The 14th paragraph relating to achieving the sales goal of $1.45 billion which positions the Company to meet its full year 2024 earnings per diluted share target of $5.15, excluding a supplemental non-recurring, non-cash impairment charge of approximately $0.07 per diluted share, associated with our trademarks.

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated January 22, 2025, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01. They are as follows:

Portion of the 4th paragraph relating to potential future Guess sales levels

The 13th paragraph relates to limited 2025 visibility, potential future demand, and strong product pipelines for 2025

The 15th paragraph relating to plans to release 2025 guidance and 2024 fourth quarter and full year consolidated results

The 16th through 19th paragraphs relating to the conference call scheduled for February 25, 2025

The 22nd paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated January 22, 2025

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: January 22, 2025

Interparfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2024
Q3

Q3 2024 Earnings

8-K

Nov 6, 2024

0001753926-24-001820

ipar-20241106.htm

NY false 0000822663

0000822663

2024-11-06 2024-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 6, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Certain portions of our press release dated November 6, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:

The 1st, 2nd (consisting of a table), 3rd, 5th, 10th, and 12th through 14th full paragraphs relating to the results of operations for the third quarter of 2024

Portions of the 7th and 11th paragraphs relating to the results of operations for the third quarter of 2024

Portion of the 4th paragraph relating to sales by territory

Portion of the 6th paragraph relating to gift set shipping and gift set inventory stock

Portion of the 8th paragraph relating to positive feedback from distributors and retailers for our 2025 new product pipeline

The 18th through 21st paragraphs relating to the previously announced conference call for 2024 third quarter results

The unaudited consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated November 6, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

Portion of the 4th paragraph relating to future promotional plans in China

Portion of the 6th paragraph relating to healthy sell-out projected for the balance of 2024

Portion of the 7th paragraph relating to future net sales for Roberto Cavalli and Lacoste by the end of 2024

Portions of the 8th paragraph relating to 2024 fourth quarter and full year results as well as 2025 growth rate prediction

The 9th paragraph relating to our company’s future operating plans in the coming years

Portion of the 11th paragraph relating to shifting the European operations’ Advertising and Promotion (A&P) activities from the third quarter to the fourth quarter to prepare for 2025

The 15th paragraph affirming 2024 guidance

The 16th paragraph relating to the initial 2025 guidance issuance date

The 24th paragraph relating to forward-looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02 or 8.01

Item 8.01 Other Events

The 17th paragraph relating to dividends

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated November 6, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: November 6, 2024

Inter Parfums, Inc.

By:  /s/

Michel Atwood

Michel Atwood

Chief Financial Officer

2024
Q3

Q3 2024 Earnings

8-K

Oct 21, 2024

0001753926-24-001723

ipar-20241021.htm

NY false 0000822663

0000822663

2024-10-21 2024-10-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 21, 2024

Interparfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Certain portions of our press release dated October 21, 2024, a copy which is annexed hereto as Exhibit No. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:

The 1st through 8th, and 10th full paragraphs relating to net sales for the third quarter or nine (9) months ended September 30, 2024

Portions of the 9th, 11th and 12th paragraph relating to net sales for the third quarter or nine (9) months ended September 30, 2024

The 14th-17th paragraphs relating to plans to release the third quarter and nine (9) months ended September 30, 2024 results and the 2024 third quarter conference call

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated October 21, 2024, a copy which is annexed hereto as Exhibit No. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulations FD. They are as follows:

Portion of the 9th paragraph relating to future net sales for Donna Karan/DKNY

Portion of the 11th paragraph relating to Roberto Cavalli products for the holiday 2024 season

Portion of the 12th paragraph relating to future market share gain

The 13th paragraph relating to reaffirming 2024 guidance and plans to issue initial 2025 guidance

The 14th paragraph relating to our plans to issue our results for the third quarter and nine (9) months ended September 30, 2024 and the conference call scheduled for November 7, 2024

The 20th paragraph relating to forward looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated October 21, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: October 21, 2024

Inter Parfums, Inc.

By:

/s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2024
Q2

Q2 2024 Earnings

8-K

Aug 6, 2024

0001753926-24-001358

ipar-20240806.htm

NY false 0000822663

0000822663

2024-08-06 2024-08-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 6, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Certain portions of our press release dated August 6, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:

The 1st paragraph, 2nd paragraph (consisting of a table), 3rd, through 5th, 11th through 13th and 15th through 16th full paragraphs relating to results of operations for the second quarter of 2024

Portions of the 9th and 14th paragraphs relating to the results of operations for the second quarter of 2024

The 8th paragraph relating to the previously announced Van Cleef & Arpels license extension

The 17th paragraph relating to balance sheet items

The 20th through 23rd paragraphs relating to the previously announced 2024 second quarter conference call scheduled for August 7, 2024

The consolidated statements of income and consolidated balance sheets

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated August 6, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

The 6th and 7th paragraphs relating to product line extensions and new product launches for the second half of 2024

Portion of the 9th paragraph relating to operations momentum for the remainder of the year

The 10th paragraph relating to new product launches anticipated for 2025

Portion of the 14th paragraph relating to budgeting of promotional and advertising expenditures for the remainder of the year

The 18th paragraph relating to reaffirming 2024 guidance

The 26th paragraph relating to forward looking information

The balance of such press release not otherwise incorporated by reference in Items 2.02 or 8.01

Item 8.01 Other Events

The 19th paragraph relating to dividends

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated August 6, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: August 6, 2024

Inter Parfums, Inc.

By:  /s/

Michel Atwood

Michel Atwood

Chief Financial Officer

2024
Q2

Q2 2024 Earnings

8-K

Jul 22, 2024

0001753926-24-001261

ipar-20240722.htm

NY false 0000822663

0000822663

2024-07-22 2024-07-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): July 22, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission File Number

(I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, NY 10176 (Address of Principal Executive Offices)

212.983.2640 (Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Certain portions of our press release dated July 22, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:

The 1st through 3rd and 7th through 8th full paragraphs relating to net sales for the second quarter and six (6) months ended June 30, 2024

Portions of the 4th, 5th, 6th, 9th and 10th paragraphs relating to net sales for the second quarter and six (6) months ended June 30, 2024

Item 7.01 Regulation FD Disclosure

Certain portions of our press release dated July 22, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

Portions of the 4th, 6th, 9th and 10th paragraphs relating to product line extensions and new product launches

Portion of the 5th paragraph relating to an expected increase in Montblanc sales

The 11th paragraph relating to maintaining 2024 guidance and factors affecting guidance

The 12th and 13th paragraphs relating to the Van Cleef and Arpels license renewal

Portion of the 14th paragraph relating to plans to release second quarter results

Portion of the 14th paragraph and the 15th through 17th full paragraphs relating to the 2024 second quarter conference call

The 20th paragraph relating to forward looking information

The balance of such press release not otherwise incorporated by reference in Item 2.02

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated July 22, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: July 22, 2024

Inter Parfums, Inc.

By:  /s/

Michel Atwood

Michel Atwood

Chief Financial Officer

2024
Q1

Q1 2024 Earnings

8-K

May 7, 2024

0001753926-24-000931

false 0000822663

0000822663

2024-05-07 2024-05-07

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May 7, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of

incorporation or organization)

Commission

File Number

(I.R.S. Employer

Identification No.)

551 Fifth Avenue, New York, NY 10176

(Address of Principal Executive Offices)

212.983.2640

(Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Conditions

Certain portions of our press release dated May 7, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

•The 1st, through, 7th, and the 10th, 13th, and 15th full paragraphs relating to results of operations for the first quarter of 2024

•Portions of the 8th, 12th and 14th relating to results of operations for the first quarter of 2024

•The 19th through 21st paragraphs relating to the Conference call to be held on May 8, 2024

•The consolidated statements of income and consolidated balance sheets

Item 7.01. Regulation FD Disclosure.

Certain portions of our press release dated May 7, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD.

•Portions of the 8th paragraph relating to certain 2024 product launches for the remainder of the year

•The 9th paragraph relating to portfolio new products launches and growth for 2024

•The 11th paragraph relating to the favorable fragrance market for our products

•Portions of the 12th paragraph relating to product price increases for the second half of 2024

•Portions of the 14th paragraph relating to advertising and promotion spending for the remainder of the year

•The 16th and 17th paragraphs relating to 2024 guidance

•The 24th paragraph relating to forward-looking information

•The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 8.01. Other Events

•The 18th paragraph relating to dividends

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated May 7, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: May 7, 2024

Inter Parfums, Inc.

By: /s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2024
Q1

Q1 2024 Earnings

8-K

Apr 24, 2024

0001753926-24-000820

false 0000822663

0000822663

2024-04-24 2024-04-24

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): April 24, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of

incorporation or organization)

Commission

File Number

(I.R.S. Employer

Identification No.)

551 Fifth Avenue, New York, NY 10176

(Address of Principal Executive Offices)

212.983.2640

(Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Conditions

Certain portions of our press release dated April 24, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

• The 1st,, 2nd, 4th, 5th, 7th, , 8th and 9th full paragraphs and portions of the 3rd and 6th paragraph relating to net sales for the first quarter ended March 31, 2024

Item 7.01. Regulation FD Disclosure.

Certain portions of our press release dated April 24, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD.

•Portions of the 3rd and 6th paragraphs relating to new product line extensions

•The 10th paragraph relating to portfolio innovations for 2024

•The 11th paragraph relating to 2024 guidance

•The 14th paragraph relating to forward-looking information

•The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated April 24, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: April 24, 2024

Inter Parfums, Inc.

By: /s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2023
Q4

Q4 2023 Earnings

8-K

Feb 27, 2024

0001753926-24-000400

false 0000822663

0000822663

2024-02-27 2024-02-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

February 27, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3255609

(State or other jurisdiction of

incorporation or organization)

Commission

File Number

(I.R.S. Employer

Identification No.)

551 Fifth Avenue, New York, New York 10176

(Address of Principal Executive Offices)

212. 983.2640

(Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 280.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 280.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 280.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§280.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Certain portions of our press release dated February 27, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

● The 1st through 6th, paragraphs and portions of the 7th, 9th and 10th paragraphs a relating to results of operations

● The 11th through 14th paragraphs relating to results of operations, and the 15th paragraph relating to balance sheet information

● The 22nd through 25th paragraphs relating to the conference call to be held on February 28, 2024

● The tables of unaudited consolidated statements of income and consolidated balance sheets

Item 7.01. Regulation FD Disclosure

Certain portions of our press release dated February 27, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

● The 8th and 9th full paragraphs and portions of the 10th paragraph relating to 2024 new product launches and brand extensions

● Paragraphs 16 through 18 relating to 2024 guidance

● Paragraphs 26 and 27, about Inter Parfums, Inc.

● Portions of the 7th paragraph and paragraph 28 relating to forward looking statements

● The balance of such press release not otherwise incorporated by reference in Items 2.02 or 8.01

Item 8.01 Other Matters

Certain portions of our press release dated February 27, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 8.01. They are as follows:

● The 19th and 20th paragraphs relating to the increase of our cash dividend are incorporated by reference herein.

● The 21st paragraph relating to the Share Buyback Program

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated February 27, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: February 27, 2024

Inter Parfums, Inc.

By: /s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2023
Q4

Q4 2023 Earnings

8-K

Jan 23, 2024

0001753926-24-000138

false 0000822663

0000822663

2024-01-23 2024-01-23

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): January 23, 2024

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of incorporation or organization)

Commission

File Number

(I.R.S. Employer

Identification No.)

551 Fifth Avenue, New York, NY 10176

(Address of Principal Executive Offices)

212.983.2640

(Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Conditions

Certain portions of our press release dated January 23, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

• The 1st through 7th paragraphs relating to net sales for the fourth quarter of 2023 and/or the full year ended December 31, 2023.

Item 7.01. Regulation FD Disclosure.

Certain portions of our press release dated January 23, 2024, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 7.01 and Regulation FD.

•The 8th paragraph relating to portfolio innovations for 2024.

•The 9th paragraph relating to 2024 guidance and plans to release 2023 fourth quarter results.

•The 12th paragraph relating to forward-looking information.

•The balance of such press release not otherwise incorporated by reference in Item 2.02.

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated January 23, 2024

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: January 23, 2024

Inter Parfums, Inc.

By: /s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2023
Q3

Q3 2023 Earnings

8-K

Nov 7, 2023

0001753926-23-001434

false 0000822663

0000822663

2023-11-07 2023-11-07

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): November 7, 2023

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of

incorporation or organization)

Commission

File Number

(I.R.S. Employer

Identification No.)

551 Fifth Avenue, New York, NY 10176

(Address of Principal Executive Offices)

212.983.2640

(Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

Certain portions of our press release dated November 7, 2023, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

● The 1st, 2nd (consisting of a table), 3rd, 7th , 8th and 9th paragraphs relating to results of operations for the third quarter of 2023

● Portions of the 4th paragraph relating to sales by territory

● The 15th – 18th paragraphs relating to the earnings conference call scheduled for November 8, 2023

● The unaudited consolidated statements of income and consolidated balance sheets

Item 7.01. Regulation FD Disclosure.

Certain portions of our press release dated November 7, 2023, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

● Portions of the 4th paragraph relating to potential sales in China for 2024

● The 5th paragraph relating to Roberto Cavalli and Lacoste licenses

● The 6th paragraph relating to advertising and promotional expenses for the 2023 fourth quarter

● The 10th – 12th paragraphs relating to guidance

● The 21st paragraph relating to forward looking information

● The balance of such press release not otherwise incorporated by reference in Item 2.02 or 8.01

Item 8.01 Other Events

● The 13th paragraph relating to our cash dividend

● The 14th paragraph relating to our share buyback program

Item 9.01 Financial Statements and Exhibits.

99.1

Our press release dated November 7, 2023

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: November 7, 2023

Inter Parfums, Inc.

By: /s/ Michel Atwood

Michel Atwood

Chief Financial Officer

2023
Q3

Q3 2023 Earnings

8-K

Oct 23, 2023

0001753926-23-001377

0000822663 false

0000822663

2023-10-23 2023-10-23

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 23, 2023

Inter Parfums, Inc.

(Exact name of Registrant as specified in its charter)

Delaware

0-16469

13-3275609

(State or other jurisdiction of

incorporation or organization)

Commission

File Number

(I.R.S. Employer

Identification No.)

551 Fifth Avenue, New York, NY 10176

(Address of Principal Executive Offices)

212.983.2640

(Registrant’s Telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange

on which registered

Common Stock, $.001 par value per share

IPAR

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

Certain portions of our press release dated October 23, 2023, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 2.02. They are as follows:

● The 1st through 6th and the 8th paragraphs relating to sales for the third quarter or nine months of 2023

● Portions of the 7th paragraph relating to sales for the third quarter of 2023

Item 7.01. Regulation FD Disclosure.

Certain portions of our press release dated October 23, 2023, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

● Portions of the 7th paragraph relating to the expected majority of the Phase 1 distribution roll-out of Abercrombie & Fitch Fierce during the fourth quarter

● The 9th paragraph relating to our expectations for meeting the 2023 holiday season demands

● The 10th paragraph relating to our plans to issue updated guidance for 2023 with our results for the third quarter of 2023

● The 13th paragraph relating to forward looking information

● The balance of such press release not otherwise incorporated by reference in Item 2.02

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated October 23, 2023

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

Dated: October 23, 2023

Inter Parfums, Inc.

By: /s/ Michel Atwood

Michel Atwood,

Chief Financial Officer

About Inter Parfums Inc. (IPAR) Earnings

This page provides Inter Parfums Inc. (IPAR) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.

Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on IPAR's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.

Share on Social Networks: